UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...

The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...

Pancreatic cancer, one of the most brutal and deadly diseases, sees approximately 10,800 new cases annually – 30 each day, in the UK – according to Cancer Research UK.It is the ...

Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...

Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...

Lehigh Valley Health Network, part of Jefferson Health, dedicated the Peter and Odete Kelly Center for Personalized Cancer Immunotherapy in a celebratory event at Lehigh Valley Hospital–Cedar Crest. A ...

Scientific Longevity Company Collaborates with Major Academic Institutions to Remove Tumor Defense Mechanisms and Help Defeat Cancer in a Non-Toxic ...

A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.

A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...